International Journal of Cardiology
Volume 139, Issue 1 , Pages 25-31, 18 February 2010

Magnetic resonance reveals long-term sequelae of apical ballooning syndrome

  • M. Neus Bellera

      Affiliations

    • Thorax Institute, IDIBAPS, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 655 45 99 61.
  • ,
  • José T. Ortiz

      Affiliations

    • Thorax Institute, IDIBAPS, Barcelona, Spain
  • ,
  • Maria Teresa Caralt

      Affiliations

    • Radiology Division at Hospital Clínic, IDIBAPS, Barcelona, Spain
  • ,
  • Jordi Pérez-Rodon

      Affiliations

    • Department of Cardiology at Hospital Josep Trueta, Girona, Spain
  • ,
  • Jaume Mercader

      Affiliations

    • Department of Cardiology at Hospital de Granollers, Barcelona, Spain
  • ,
  • Carlos Fernández-Gómez

      Affiliations

    • Department of Cardiology at Hospital Mutua de Terrassa, Barcelona, Spain
  • ,
  • Carles Paré

      Affiliations

    • Thorax Institute, IDIBAPS, Barcelona, Spain
  • ,
  • Magda Heras

      Affiliations

    • Thorax Institute, IDIBAPS, Barcelona, Spain

Received 27 April 2008; accepted 10 August 2008. published online 22 September 2008.

Abstract 

Background

The presence of small areas of necrosis has been occasionally reported immediately following apical ballooning syndrome (ABS). However, their persistence at later stages and impact on long-term prognosis are currently unknown.

Methods

Twenty consecutive patients admitted for ABS between 2004 and 2007 were prospectively evaluated. Demographic, clinical, angiographic, and echocardiographic data were collected during hospital admission. At a mean of 11±9 months follow-up, a contrast enhanced cardiac magnetic resonance (ce-CMR) study was performed in 17 cases. The presence of hyperenhancement on ce-CMR images, reflecting irreversible myocardial damage, was recorded by two independent observers.

Results

Two of 3 patients with hyperenhancement on ce-CMR images presented in worse condition, including pulmonary edema or cardiogenic shock, compared to just 2 of 14 patients without hyperenhancement (p=0.052). Segmental wall motion substantially improved in both of those cases; the third patient continued to have hypokinesis in a segment showing hyperenhancement. Segmental wall motion also significantly improved in all patients with no hyperenhancement. At a mean of 20±12 months follow-up, no deaths or major adverse cardiac events were documented among patients with or without hyperenhancement.

Conclusions

Despite segmental wall motion recovery, an area of irreversible myocardial damage can sometimes be identified long after ABS. However, in this limited series of patients, the presence of scar, even when presenting with heart failure and a higher troponin release, was not associated with adverse long-term outcomes as compared to patients with intact myocardium.

Keywords: Tako-tsubo cardiomyopathy, Viability, Magnetic resonance imaging, Echocardiography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-5273(08)00983-2

doi:10.1016/j.ijcard.2008.08.023

International Journal of Cardiology
Volume 139, Issue 1 , Pages 25-31, 18 February 2010